Analyst Ratings for Eloxx Pharma (ELOX)
ELOX Rating Summary
ELOX Price Target Summary
- Highest: $43.00 (Guggenheim)
- Lowest: $38.00 (Lucid Capital Markets)
- Average: $40.33
* Over Last 12-Mos
Overall Rating:
BUY
Rating Trend:
Avg. $ Target:
$40.33 (+159.9%)
* Over Last 12-Mos
Rating Score: 8.2 / 10
Percentile Rank: 84%
Avg. $ Target:
$40.33 (+159.9%)
* Over Last 12-Mos
Rating Score: 8.2 / 10
Percentile Rank: 84%
| Date | Firm | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 8/20/2026 | Lucid Capital Markets | Dev Prasad | New Coverage | Buy (N/A) |
38.00 (N/A) |
18.16 (15.52) |
-14.54% | Details |
| 7/22/2026 | LifeSci Capital | Rami Katkhuda | New Coverage | Outperform (N/A) |
40.00 (N/A) |
12.00 (15.52) |
29.33% | Details |
 |
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
